
Gigi Georgiana Huang
Examiner (ID: 703, Phone: (571)272-9073 , Office: P/1621 )
| Most Active Art Unit | 1613 |
| Art Unit(s) | 1618, 1609, 1612, 1629, 1621, 1617, 1613, 1627 |
| Total Applications | 773 |
| Issued Applications | 215 |
| Pending Applications | 86 |
| Abandoned Applications | 496 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6055706
[patent_doc_number] => 20110112066
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-12
[patent_title] => 'PREVENTIVE/REMEDY FOR RETINAL NERVE DISEASES CONTAINING ALKYL ETHER DERIVATIVES OR SALTS THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/008982
[patent_app_country] => US
[patent_app_date] => 2011-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30249
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0112/20110112066.pdf
[firstpage_image] =>[orig_patent_app_number] => 13008982
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/008982 | Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof | Jan 18, 2011 | Issued |
Array
(
[id] => 8502070
[patent_doc_number] => 20120301478
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-29
[patent_title] => 'Pharmaceutical for Preventing or Treating Disorders Accompanied by Ocular Angiogenesis and/or Elevated Ocular Vascular Permeability'
[patent_app_type] => utility
[patent_app_number] => 13/521395
[patent_app_country] => US
[patent_app_date] => 2011-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6198
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13521395
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/521395 | Pharmaceutical for Preventing or Treating Disorders Accompanied by Ocular Angiogenesis and/or Elevated Ocular Vascular Permeability | Jan 12, 2011 | Abandoned |
Array
(
[id] => 7733406
[patent_doc_number] => 20120015912
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-19
[patent_title] => 'USE OF 2,5-DIHYDROXYBENZENE FOR THE TREATMENT OF OCULAR DISEASES'
[patent_app_type] => utility
[patent_app_number] => 12/986674
[patent_app_country] => US
[patent_app_date] => 2011-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 25490
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20120015912.pdf
[firstpage_image] =>[orig_patent_app_number] => 12986674
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/986674 | Use of 2,5-dihydroxybenzene for the treatment of ocular diseases | Jan 6, 2011 | Issued |
Array
(
[id] => 8503193
[patent_doc_number] => 20120302601
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-29
[patent_title] => 'COMPOSITIONS AND METHODS FOR THE TREATMENT OF MACULAR DEGENERATION'
[patent_app_type] => utility
[patent_app_number] => 13/514769
[patent_app_country] => US
[patent_app_date] => 2010-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3837
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13514769
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/514769 | Compositions and methods for the treatment of macular degeneration | Dec 8, 2010 | Issued |
Array
(
[id] => 6118645
[patent_doc_number] => 20110076318
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-31
[patent_title] => 'RETINOID-CONTAINING SUSTAINED RELEASE INTRAOCULAR IMPLANTS AND RELATED MATTERS'
[patent_app_type] => utility
[patent_app_number] => 12/962427
[patent_app_country] => US
[patent_app_date] => 2010-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 51
[patent_figures_cnt] => 51
[patent_no_of_words] => 23624
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20110076318.pdf
[firstpage_image] =>[orig_patent_app_number] => 12962427
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/962427 | RETINOID-CONTAINING SUSTAINED RELEASE INTRAOCULAR IMPLANTS AND RELATED MATTERS | Dec 6, 2010 | Abandoned |
Array
(
[id] => 5995497
[patent_doc_number] => 20110114517
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-19
[patent_title] => 'HYDROGEN PEROXIDE SOLUTION AND KIT FOR DISINFECTING CONTACT LENSES'
[patent_app_type] => utility
[patent_app_number] => 12/948195
[patent_app_country] => US
[patent_app_date] => 2010-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8926
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0114/20110114517.pdf
[firstpage_image] =>[orig_patent_app_number] => 12948195
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/948195 | HYDROGEN PEROXIDE SOLUTION AND KIT FOR DISINFECTING CONTACT LENSES | Nov 16, 2010 | Abandoned |
Array
(
[id] => 6127830
[patent_doc_number] => 20110086844
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-14
[patent_title] => 'Oral Solid Solution Formulation of a Poorly Water-Soluble Active Substance'
[patent_app_type] => utility
[patent_app_number] => 12/945570
[patent_app_country] => US
[patent_app_date] => 2010-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4220
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20110086844.pdf
[firstpage_image] =>[orig_patent_app_number] => 12945570
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/945570 | Oral Solid Solution Formulation of a Poorly Water-Soluble Active Substance | Nov 11, 2010 | Abandoned |
Array
(
[id] => 6025785
[patent_doc_number] => 20110053845
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-03
[patent_title] => 'LOCALIZED VAGINAL DELIVERY WITHOUT DETRIMENTAL BLOOD LEVELS'
[patent_app_type] => utility
[patent_app_number] => 12/941840
[patent_app_country] => US
[patent_app_date] => 2010-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7297
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20110053845.pdf
[firstpage_image] =>[orig_patent_app_number] => 12941840
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/941840 | LOCALIZED VAGINAL DELIVERY WITHOUT DETRIMENTAL BLOOD LEVELS | Nov 7, 2010 | Abandoned |
Array
(
[id] => 6071182
[patent_doc_number] => 20110046033
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-24
[patent_title] => 'Multipurpose Lens Care Solution with Benefits to Corneal Epithelial Barrier Function'
[patent_app_type] => utility
[patent_app_number] => 12/939262
[patent_app_country] => US
[patent_app_date] => 2010-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10135
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0046/20110046033.pdf
[firstpage_image] =>[orig_patent_app_number] => 12939262
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/939262 | Multipurpose Lens Care Solution with Benefits to Corneal Epithelial Barrier Function | Nov 3, 2010 | Abandoned |
Array
(
[id] => 8465785
[patent_doc_number] => 20120270954
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-25
[patent_title] => 'METHODS FOR MAINTAINING EYE HEALTH AND AMELIORATING OPTHALMIC MALADIES IN CANINES'
[patent_app_type] => utility
[patent_app_number] => 13/503953
[patent_app_country] => US
[patent_app_date] => 2010-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5092
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13503953
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/503953 | METHODS FOR MAINTAINING EYE HEALTH AND AMELIORATING OPTHALMIC MALADIES IN CANINES | Oct 21, 2010 | Abandoned |
Array
(
[id] => 6196758
[patent_doc_number] => 20110028516
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-03
[patent_title] => 'STABILIZED AND PRESERVED KETOIFEN OPHTHALMIC COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 12/904675
[patent_app_country] => US
[patent_app_date] => 2010-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2481
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20110028516.pdf
[firstpage_image] =>[orig_patent_app_number] => 12904675
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/904675 | STABILIZED AND PRESERVED KETOIFEN OPHTHALMIC COMPOSITIONS | Oct 13, 2010 | Abandoned |
Array
(
[id] => 10567552
[patent_doc_number] => 09290710
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-03-22
[patent_title] => 'Synergistic antimicrobial composition'
[patent_app_type] => utility
[patent_app_number] => 13/500220
[patent_app_country] => US
[patent_app_date] => 2010-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3147
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13500220
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/500220 | Synergistic antimicrobial composition | Oct 7, 2010 | Issued |
Array
(
[id] => 9375250
[patent_doc_number] => 08679511
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-03-25
[patent_title] => 'In-situ gel ophthalmic drug delivery system of estradiol or other estrogen for prevention of cataracts'
[patent_app_type] => utility
[patent_app_number] => 12/924495
[patent_app_country] => US
[patent_app_date] => 2010-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3551
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12924495
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/924495 | In-situ gel ophthalmic drug delivery system of estradiol or other estrogen for prevention of cataracts | Sep 27, 2010 | Issued |
Array
(
[id] => 5944994
[patent_doc_number] => 20110105614
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-05
[patent_title] => 'High Concentration Baclofen Preparations'
[patent_app_type] => utility
[patent_app_number] => 12/892627
[patent_app_country] => US
[patent_app_date] => 2010-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7077
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20110105614.pdf
[firstpage_image] =>[orig_patent_app_number] => 12892627
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/892627 | High concentration baclofen preparations | Sep 27, 2010 | Issued |
Array
(
[id] => 8382310
[patent_doc_number] => 20120225947
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-06
[patent_title] => 'RETINAL NEUROPROTECTION BY ION CHANNEL BLOCKERS REGULATED BY THE SUR SUBUNIT'
[patent_app_type] => utility
[patent_app_number] => 13/497938
[patent_app_country] => US
[patent_app_date] => 2010-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8109
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13497938
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/497938 | RETINAL NEUROPROTECTION BY ION CHANNEL BLOCKERS REGULATED BY THE SUR SUBUNIT | Sep 22, 2010 | Abandoned |
Array
(
[id] => 6342720
[patent_doc_number] => 20100329991
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-30
[patent_title] => 'Medicinal preparation particularly for the treatment of slipped discs hernias'
[patent_app_type] => utility
[patent_app_number] => 12/870258
[patent_app_country] => US
[patent_app_date] => 2010-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 1912
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0329/20100329991.pdf
[firstpage_image] =>[orig_patent_app_number] => 12870258
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/870258 | Medicinal preparation particularly for the treatment of slipped discs hernias | Aug 26, 2010 | Issued |
Array
(
[id] => 8253194
[patent_doc_number] => 20120157521
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-21
[patent_title] => 'TREATMENT OF MACULAR DEGENERATION'
[patent_app_type] => utility
[patent_app_number] => 13/392435
[patent_app_country] => US
[patent_app_date] => 2010-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 8686
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0157/20120157521.pdf
[firstpage_image] =>[orig_patent_app_number] => 13392435
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/392435 | TREATMENT OF MACULAR DEGENERATION | Aug 26, 2010 | Abandoned |
Array
(
[id] => 6630414
[patent_doc_number] => 20100311716
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-09
[patent_title] => 'USE OF INHIBITORS OF JUN N-TERMINAL KINASES TO TREAT GLAUCOMA'
[patent_app_type] => utility
[patent_app_number] => 12/858739
[patent_app_country] => US
[patent_app_date] => 2010-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4836
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0311/20100311716.pdf
[firstpage_image] =>[orig_patent_app_number] => 12858739
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/858739 | USE OF INHIBITORS OF JUN N-TERMINAL KINASES TO TREAT GLAUCOMA | Aug 17, 2010 | Abandoned |
Array
(
[id] => 6562977
[patent_doc_number] => 20100272791
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-28
[patent_title] => 'COMPOSITION HAVING EFFECT ON TREATMENT AND PREVENTION OF DRY EYE SYNDROME'
[patent_app_type] => utility
[patent_app_number] => 12/832395
[patent_app_country] => US
[patent_app_date] => 2010-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5548
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0272/20100272791.pdf
[firstpage_image] =>[orig_patent_app_number] => 12832395
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/832395 | COMPOSITION HAVING EFFECT ON TREATMENT AND PREVENTION OF DRY EYE SYNDROME | Jul 7, 2010 | Abandoned |
Array
(
[id] => 6448667
[patent_doc_number] => 20100280089
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-04
[patent_title] => 'USE OF INHIBITORS OF JUN N-TERMINAL KINASES FOR THE TREATMENT OF GLAUCOMATOUS RETINOPATHY AND OCULAR DISEASES'
[patent_app_type] => utility
[patent_app_number] => 12/831702
[patent_app_country] => US
[patent_app_date] => 2010-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4171
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0280/20100280089.pdf
[firstpage_image] =>[orig_patent_app_number] => 12831702
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/831702 | USE OF INHIBITORS OF JUN N-TERMINAL KINASES FOR THE TREATMENT OF GLAUCOMATOUS RETINOPATHY AND OCULAR DISEASES | Jul 6, 2010 | Abandoned |